Prosecution Insights
Last updated: May 29, 2026

Sullivan & Worcester LLP

24 pending office actions • 14 clients • 24 examiners • 18 art units • 0 of 24 (0%) have an AI response strategy ready • 34 patents granted in the last 365 days

Portfolio Summary

24
Total Pending OAs
16
Non-Final OAs
7
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 24 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

9
Overdue
1
Due this week
10
Due this month
1
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 24 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (9)Due ≤ 7 days (1)Due ≤ 30 days (10)Due ≤ 60 days (1)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (8%)
14
Medium (58%)
0
Easy (0%)
8
Unknown (33%)

Rejection Statute Mix

BucketCases
§101 only2 (8%)
§103 only13 (54%)
§102 only1 (4%)
No statute on record8 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

17
Life Sciences
71% of docket
1
Information Tech
4% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
6
Mechanical / Eng
25% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

240 h
Manual time on pending OAs
48 h
Time saved (low, 20%)
84 h
Time saved (mid, 35%)
2.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CHAN, KO HUNG 1 66.2% +15.4%
JOHNSON, NICOLE F 1 87.4% +7.2%
KIM, YOUNG J 1 64.8% +17.9%
THUESON, HANNA MARIE 1 71.4% +30.8%
WASHINGTON, BRITNEY NICOLE 1 83.3% +19.5%
BAUSCH, SARAE L 1 29.0% +43.8%
GREENE, CAROLYN LEE 1 64.9% +49.7%
MARCETICH, ADAM M 1 72.4% +19.0%
ANTISKAY, BRIAN MICHAEL 1 66.5% +40.2%
ANTHOPOLOS, PETER 1 57.2% +58.8%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18627895 ALGORITHMIC TECHNIQUES FOR DEDUCTION OF FUNCTIONAL CHARACTERISTICS OF CARDIAC TISSUE IN CARDIAC ELECTRICAL FIBRILLATION FROM A DENSELY PACKED ARRAY OF HIGH-RESOLUTION ELECTRODES JOHNSON, NICOLE F 29d
18347377 TISSUE CHAMBER WASHINGTON, BRITNEY NICOLE 71d

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18266404 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA BAUSCH, SARAE L 12d
16739814 MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS COLEMAN, CHARLES P. 15d
18580422 COMPOSITIONS AND METHODS FOR DETECTION OF LIVER CANCER KIM, YOUNG J 33d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17970906 COMPOSITIONS AND METHODS FOR TREATING BIOFILMS ANTHOPOLOS, PETER 73d overdue
18204703 DETECTION OF TARGET NUCLEIC ACIDS GREENE, CAROLYN LEE 43d overdue
19054047 COLUMN TUBE HOLDER FOR IMPROVED-ACCURACY ASSAYS CHAN, KO HUNG 17d overdue
18087165 METHODS FOR CANCER TREATMENT MARCETICH, ADAM M 5d
18086143 DEVICES AND METHODS FOR TISSUE MAPPING ANTISKAY, BRIAN MICHAEL 8d
18266404 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA BAUSCH, SARAE L 12d
18580422 COMPOSITIONS AND METHODS FOR DETECTION OF LIVER CANCER KIM, YOUNG J 33d
18347377 TISSUE CHAMBER WASHINGTON, BRITNEY NICOLE 71d

Client Portfolio (14 clients)

Top Art Units

Art UnitApps
16813
16823
17972
37942
36311
37961
16381
16991
37811
16111

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19054047 COLUMN TUBE HOLDER FOR IMPROVED-ACCURACY ASSAYS Mercy Bioanalytics, Inc. CHAN, KO HUNG 3631 §103 Non-Final OA 17d overdue Pending Feb 14, 2025
18627895 ALGORITHMIC TECHNIQUES FOR DEDUCTION OF FUNCTIONAL CHARACTERISTICS OF CARDIAC TISSUE IN CARDIAC ELECTRICAL FIBRILLATION FROM A DENSELY PACKED ARRAY OF HIGH-RESOLUTION ELECTRODES Coremap, Inc. JOHNSON, NICOLE F 3796 §102 Non-Final OA 29d Pending Apr 05, 2024
18580422 COMPOSITIONS AND METHODS FOR DETECTION OF LIVER CANCER Mercy Bioanalytics, Inc. KIM, YOUNG J 1681 §101 Non-Final OA 33d Pending Jan 18, 2024
18347348 TISSUE PROCESSING Applikate Technologies, Inc. THUESON, HANNA MARIE 1638 §103 Non-Final OA 83d Pending Jul 05, 2023
18347377 TISSUE CHAMBER Applikate Technologies, Inc. WASHINGTON, BRITNEY NICOLE 1797 §103 Non-Final OA 71d Pending Jul 05, 2023
18266404 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA The University of Chicago BAUSCH, SARAE L 1699 Other Non-Final OA 12d Pending Jun 10, 2023
18204703 DETECTION OF TARGET NUCLEIC ACIDS Saga Diagnostics AB GREENE, CAROLYN LEE 1681 Other Non-Final OA 43d overdue Pending Jun 01, 2023
18087165 METHODS FOR CANCER TREATMENT Droplet Biosciences, Inc. MARCETICH, ADAM M 3781 §103 Final Rejection 5d Pending Dec 22, 2022
18086143 DEVICES AND METHODS FOR TISSUE MAPPING Coremap, Inc. ANTISKAY, BRIAN MICHAEL 3794 §103 Non-Final OA 8d Pending Dec 21, 2022
17970906 COMPOSITIONS AND METHODS FOR TREATING BIOFILMS Wiab Water Innovation AB ANTHOPOLOS, PETER 1611 Other Final Rejection 73d overdue Pending Oct 21, 2022
17934428 THERAPEUTICS FOR HAPLOINSUFFICIENCY CONDITIONS Quelltx, Inc. TRAN, CHRISTINA L 1637 §103 Non-Final OA 27d Pending Sep 22, 2022
17947861 METHODS FOR DISEASE ASSESSMENT USING DRAIN FLUID The Washington University PAGUIO FRISING, MICHELLE F 1651 Other Final Rejection 22d Pending Sep 19, 2022
17947871 LYMPHATIC FLUID FOR DIAGNOSTICS The Washington University MYERS, CARLA J 1682 Other Non-Final OA 30d overdue Pending Sep 19, 2022
17901190 CELLULAR MEASUREMENT CALIBRATION AND CLASSIFICATION Travera, Inc. HYUN, PAUL SANG HWA 1796 §103 Non-Final OA 8d Pending Sep 01, 2022
17793382 COMPOSITIONS AND METHODS FOR DETECTION OF OVARIAN CANCER Mercy Bioanalytics, Inc. BUCHANAN, BAILEY CHEYENNE 1682 §103 Final Rejection 9d overdue Pending Jul 15, 2022
17856072 METHODS FOR SELECTIVELY SUPPRESSING NON-TARGET SEQUENCES Molecular Loop Biosciences, Inc. GUSSOW, ANNE 1683 Other Non-Final OA 99d overdue Pending Jul 01, 2022
17837689 BIOCIDAL COMPOSITIONS AND METHODS OF MAKING THE SAME Wiab Water Innovation AB SONG, JIANFENG 1613 §103 Final Rejection 22d Pending Jun 10, 2022
17732769 CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT Travera, Inc. JARRETT, LORE RAMILLANO 1797 Other Non-Final OA 114d overdue Pending Apr 29, 2022
17713690 ENHANCED LINKED TARGET CAPTURE Ncan Genomics, Inc. KENNEDY, SARAH JANE 1682 §103 Final Rejection 19d Pending Apr 05, 2022
17547616 DYNAMIC TRANSFER FUNCTION FOR REVERSIBLE ENCODING Contrast, Inc. WERNER, DAVID N 2487 §103 Final Rejection 23d overdue Pending Dec 10, 2021
17403811 CATHETER SYSTEMS AND RELATED METHODS FOR MAPPING, MINIMIZING, AND TREATING CARDIAC FIBRILLATION University Of Vermont And State Agricultural College LEE, DAVINA EN-YIN 3794 §103 Non-Final OA 1d overdue Pending Aug 16, 2021
17369620 COMPOSITIONS AND METHODS TO DISINFECT, TREAT AND PREVENT MICROBIAL INFECTIONS Wiab Water Innovation AB WHEELER, THURMAN MICHAEL 1619 §103 Non-Final OA 70d Pending Jul 07, 2021
17361829 DETECTION OF TARGET NUCLEIC ACID AND VARIANTS Saga Diagnostics AB OYEYEMI, OLAYINKA A 1681 Other Non-Final OA 14d Pending Jun 29, 2021
16739814 MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS Travera, Inc. COLEMAN, CHARLES P. 3683 §101 Non-Final OA 15d Pending Jan 10, 2020

Managing Sullivan & Worcester LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month